| Enhanced CREB and DARPP‐32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine‐conditioned … TF Tropea, BE Kosofsky, AM Rajadhyaksha Journal of neurochemistry 106 (4), 1780-1790, 2008 | 92 | 2008 |
| A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology J Wie, Z Liu, H Song, TF Tropea, L Yang, H Wang, Y Liang, C Cang, ... Nature 591 (7850), 431-437, 2021 | 90 | 2021 |
| Cav1. 2 L-type Ca2+ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Cav1. 3 channels K Schierberl, J Hao, TF Tropea, S Ra, TP Giordano, Q Xu, SM Garraway, ... Journal of Neuroscience 31 (38), 13562-13575, 2011 | 88 | 2011 |
| Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease WW Aamodt, T Waligorska, J Shen, TF Tropea, A Siderowf, D Weintraub, ... Movement Disorders 36 (12), 2945-2950, 2021 | 87 | 2021 |
| NMDA receptors in the rat VTA: a critical site for social stress to intensify cocaine taking HE Covington, TF Tropea, AM Rajadhyaksha, BE Kosofsky, KA Miczek Psychopharmacology 197, 203-216, 2008 | 84 | 2008 |
| GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein ME Diaz-Ortiz, Y Seo, M Posavi, M Carceles Cordon, E Clark, N Jain, ... Science 377 (6608), eabk0637, 2022 | 77 | 2022 |
| Molecular switch from L-type Cav1. 3 to Cav1. 2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity TP Giordano, TF Tropea, SS Satpute, MJ Sinnegger-Brauns, J Striessnig, ... Journal of Neuroscience 30 (50), 17051-17062, 2010 | 67 | 2010 |
| TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia TF Tropea, J Mak, MH Guo, SX Xie, E Suh, J Rick, A Siderowf, ... Annals of neurology 85 (6), 801-811, 2019 | 64 | 2019 |
| Enhancing VTA Cav1. 3 L-type Ca2+ channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens A Martínez-Rivera, J Hao, TF Tropea, TP Giordano, M Kosovsky, RC Rice, ... Molecular psychiatry 22 (12), 1735-1745, 2017 | 56 | 2017 |
| Overcoming barriers to Parkinson disease trial participation: increasing diversity and novel designs for recruitment and retention PA Vaswani, TF Tropea, N Dahodwala Neurotherapeutics 17 (4), 1724-1735, 2020 | 43 | 2020 |
| APOE, thought disorder, and SPARE‐AD predict cognitive decline in established Parkinson's disease TF Tropea, SX Xie, J Rick, LM Chahine, N Dahodwala, J Doshi, ... Movement Disorders 33 (2), 289-297, 2018 | 43 | 2018 |
| Abnormal B-cell and Tfh-cell profiles in patients with Parkinson disease: a cross-sectional study R Li, TF Tropea, LR Baratta, L Zuroff, ME Diaz-Ortiz, B Zhang, K Shinoda, ... Neurology: Neuroimmunology & Neuroinflammation 9 (2), e1125, 2021 | 36 | 2021 |
| Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease MT Uemura, JL Robinson, KAQ Cousins, TF Tropea, DC Kargilis, ... Acta neuropathologica 143 (1), 15-31, 2022 | 33 | 2022 |
| Cognitive profile and markers of Alzheimer disease–type pathology in patients with Lewy body dementias E Howard, DJ Irwin, K Rascovsky, N Nevler, S Shellikeri, TF Tropea, ... Neurology 96 (14), e1855-e1864, 2021 | 32 | 2021 |
| Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age L Zuroff, A Rezk, K Shinoda, DA Espinoza, Y Elyahu, B Zhang, AA Chen, ... EBioMedicine 82, 2022 | 23 | 2022 |
| The commercial genetic testing landscape for Parkinson's disease L Cook, J Schulze, J Verbrugge, JC Beck, KS Marder, ... Parkinsonism & related disorders 92, 107-111, 2021 | 22 | 2021 |
| Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurology L Dratch, RA Paul, A Baldwin, M Brzozowski, P Gonzalez‐Alegre, ... Journal of Genetic Counseling 30 (4), 974-983, 2021 | 21 | 2021 |
| Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting L Blömeke, M Pils, V Kraemer-Schulien, A Dybala, A Schaffrath, ... npj Parkinson's Disease 8 (1), 68, 2022 | 20 | 2022 |
| Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson Disease TF Tropea, AS Chen-Plotkin Parkinsonism & related disorders 46, S15-S18, 2018 | 20 | 2018 |
| Elevated plasma phosphorylated tau 181 in amyotrophic lateral sclerosis KAQ Cousins, LM Shaw, S Shellikeri, L Dratch, L Rosario, LB Elman, ... Annals of neurology 92 (5), 807-818, 2022 | 19 | 2022 |
Alice Chen-PlotkinParker Family Professor of Neurology, University of Pennsylvania在 pennmedicine.upenn.edu 的电子邮件经过验证
Alice Chen-PlotkinParker Family Professor of Neurology, University of Pennsylvania在 pennmedicine.upenn.edu 的电子邮件经过验证
"K* Miczek*Tufts Univ在 tufts.edu 的电子邮件经过验证